Pillstats
Tablet, Film Coated, Extended Release

Metoprolol Succinate

Metoprolol Succinate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6918
US makers1 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.031$0.063$0.094$0.126Dec 2025Apr 2026Jul 2026
$0.101
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

20K40K60K80K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.8K
Rx · 2026 Q1
369K
Units dispensed
-92%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown5SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 29, 2026
    RECALLRecall (Class II): Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 table…

    Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide

  • Jan 29, 2026
    RECALLRecall (Class II): Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles…

    Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide

  • Jan 29, 2026
    RECALLRecall (Class II): Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles…

    Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide

  • Jan 29, 2026
    RECALLRecall (Class II): Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, …

    Failed Dissolution Specifications — Recalling firm: Teva Pharmaceuticals USA, Inc — Nationwide

  • Jan 26, 2022
    RECALLRecall (Class II): Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North…

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA